Rochelle E Curtis

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study
    Bassam Ghabach
    Department of Veterans Affairs Medical Center, Medical Service 111, 921 NE 13th Street, Oklahoma City, OK 73104, USA
    Breast Cancer Res 12:R54. 2010
  2. ncbi request reprint Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer
    Rochelle E Curtis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892 7362, USA
    J Natl Cancer Inst 96:70-4. 2004
  3. pmc Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study
    Rochelle E Curtis
    Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Executive Plaza South, Suite 7042, 6120 Executive Blvd, Bethesda, MD 20892, USA
    Blood 105:3802-11. 2005
  4. pmc Radiation dose and subsequent risk for stomach cancer in long-term survivors of cervical cancer
    Ruth A Kleinerman
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Rockville, Maryland, USA
    Int J Radiat Oncol Biol Phys 86:922-9. 2013
  5. pmc Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008
    Lindsay M Morton
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    Blood 121:2996-3004. 2013
  6. pmc Comparison of second cancer risks from brachytherapy and external beam therapy after uterine corpus cancer
    Stefan Lonn
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland, USA
    Cancer Epidemiol Biomarkers Prev 19:464-74. 2010
  7. pmc Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors
    Deirdre A Hill
    Division of Cancer Epidemiology and Genetics and Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
    Blood 106:3358-65. 2005
  8. pmc The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor status
    Sara J Schonfeld
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA
    Cancer Causes Control 23:1721-8. 2012
  9. ncbi request reprint Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study
    Catherine Metayer
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA
    Blood 101:2015-23. 2003
  10. pmc Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries
    Amy Berrington de Gonzalez
    Radiation Epidemiology Branch, National Cancer Institute, Bethesda, MD 20892, USA
    Lancet Oncol 12:353-60. 2011

Detail Information

Publications31

  1. pmc Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study
    Bassam Ghabach
    Department of Veterans Affairs Medical Center, Medical Service 111, 921 NE 13th Street, Oklahoma City, OK 73104, USA
    Breast Cancer Res 12:R54. 2010
    ..We sought to provide new population-based information on breast-ACC incidence, relative survival, and associated cancer risk in the United States...
  2. ncbi request reprint Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer
    Rochelle E Curtis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892 7362, USA
    J Natl Cancer Inst 96:70-4. 2004
    ..These findings indicate that tamoxifen may have delayed effects, such as the increased risk of MMMTs, rare but aggressive tumors of unclear pathogenesis...
  3. pmc Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study
    Rochelle E Curtis
    Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Executive Plaza South, Suite 7042, 6120 Executive Blvd, Bethesda, MD 20892, USA
    Blood 105:3802-11. 2005
    ..Our results also suggest that clinical screening for SCC is appropriate among patients exposed to persistent chronic GVHD, prolonged immunosuppressive therapy, or both...
  4. pmc Radiation dose and subsequent risk for stomach cancer in long-term survivors of cervical cancer
    Ruth A Kleinerman
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Rockville, Maryland, USA
    Int J Radiat Oncol Biol Phys 86:922-9. 2013
    ..To assess the dose-response relationship for stomach cancer after radiation therapy for cervical cancer...
  5. pmc Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008
    Lindsay M Morton
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    Blood 121:2996-3004. 2013
    ..tAML risks should be weighed against the benefits of chemotherapy, particularly for new agents and new indications for standard agents...
  6. pmc Comparison of second cancer risks from brachytherapy and external beam therapy after uterine corpus cancer
    Stefan Lonn
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland, USA
    Cancer Epidemiol Biomarkers Prev 19:464-74. 2010
    ..Adjuvant radiotherapy is common for uterine corpus cancer patients, yet the long-term carcinogenic effects of different types of radiotherapy have not been studied adequately...
  7. pmc Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors
    Deirdre A Hill
    Division of Cancer Epidemiology and Genetics and Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
    Blood 106:3358-65. 2005
    ..The additional increased relative risk of breast cancer after RT for HL is unlikely to be larger among women with a family history of breast or ovarian cancer than among other women...
  8. pmc The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor status
    Sara J Schonfeld
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA
    Cancer Causes Control 23:1721-8. 2012
    ..It is unknown whether second lung cancer risk varies by estrogen receptor (ER) expression of the first breast cancer...
  9. ncbi request reprint Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study
    Catherine Metayer
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA
    Blood 101:2015-23. 2003
    ..Transplantation-related factors may also modulate this risk; however, the apparent contribution of high-dose TBI requires confirmation...
  10. pmc Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries
    Amy Berrington de Gonzalez
    Radiation Epidemiology Branch, National Cancer Institute, Bethesda, MD 20892, USA
    Lancet Oncol 12:353-60. 2011
    ..We aimed to estimate the proportion of second cancers attributable to radiotherapy in adults with data from the US Surveillance, Epidemiology and End Results (SEER) cancer registries...
  11. pmc Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
    Ola Landgren
    Division of Cancer Epidemiology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    Blood 113:4992-5001. 2009
    ..Our findings identify subgroups of patients who underwent allogeneic HCT at elevated risk of PTLDs for whom prospective monitoring of Epstein-Barr virus activation and early treatment intervention may be particularly beneficial...
  12. ncbi request reprint Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years
    Graca M Dores
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Executive Plaza South, Suite 7039, Bethesda, MD 20892, USA
    J Clin Oncol 20:3484-94. 2002
    ....
  13. pmc Risk of radiation-related salivary gland carcinomas among survivors of Hodgkin lymphoma: a population-based analysis
    Houda Boukheris
    Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Cancer 113:3153-9. 2008
    ..Radiotherapy for Hodgkin lymphoma (HL) increases the risk of salivary gland carcinomas (SGC). To the authors' knowledge, however, the magnitude of the risk has not been assessed to date...
  14. pmc Stomach cancer risk after treatment for hodgkin lymphoma
    Lindsay M Morton
    Lindsay M Morton, Graça M Dores, Rochelle E Curtis, Ethel S Gilbert, Ruth A Kleinerman, and Joseph F Fraumeni Jr, National Cancer Institute, Bethesda, MD Graça M Dores, Department of Veterans Affairs Medical Center, Oklahoma City, OK Charles F Lynch, University of Iowa, Iowa City, IA Marilyn Stovall, Susan A Smith, and Rita E Weathers, University of Texas MD Anderson Cancer Center, Houston, TX Per Hall and Magnus Kaijser, Karolinska Institute, Stockholm, Sweden David C Hodgson and Eric J Holowaty, University of Toronto, Toronto, Ontario, Canada Hans H Storm, Danish Cancer Society Michael Andersson, Copenhagen University Hospital, Copenhagen, Denmark Tom Børge Johannesen and Frøydis Langmark, Cancer Registry of Norway Sophie D Fossa, Oslo University Hospital and University of Oslo, Oslo, Norway Michael Hauptmann, Alexandra W Van den Belt Dusebout, Berthe M Aleman, and Flora E van Leeuwen, Netherlands Cancer Institute, Amsterdam, National Cancer Institute of Milan
    J Clin Oncol 31:3369-77. 2013
    ..Treatment-related stomach cancer is an important cause of morbidity and mortality among the growing number of Hodgkin lymphoma (HL) survivors, but risks associated with specific HL treatments are unclear...
  15. doi request reprint Radiation dose to the esophagus from breast cancer radiation therapy, 1943-1996: an international population-based study of 414 patients
    Stephanie Lamart
    Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Int J Radiat Oncol Biol Phys 86:694-701. 2013
    ....
  16. pmc The association between cancer and amyotrophic lateral sclerosis
    D Michal Freedman
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health DHHS, 6120 Executive Blvd, Bethesda, MD 20892 7238, USA
    Cancer Causes Control 24:55-60. 2013
    ..Few epidemiologic studies have examined the relationship between cancer and amyotrophic lateral sclerosis (ALS), another major neurodegenerative disease. This study addresses that gap...
  17. pmc Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype
    Lindsay M Morton
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD 20892, USA
    J Clin Oncol 28:4935-44. 2010
    ....
  18. pmc Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States
    Houda Boukheris
    Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute NIH, Bethesda, Maryland, USA
    Cancer Epidemiol Biomarkers Prev 18:2899-906. 2009
    ..Carcinomas of the major salivary glands (M-SGC) comprise a morphologically diverse group of rare tumors of largely unknown cause. To gain insight into etiology, we evaluated incidence of M-SGC using the WHO classification schema (WHO-2005)...
  19. ncbi request reprint Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology
    Graca M Dores
    Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services DHHS, National Cancer Institute NCI, National Institutes of Health NIH, Bethesda, MD, USA
    Br J Haematol 139:809-19. 2007
    ..Avenues of future research include assessment of delayed- and under-reporting to cancer registries and exploration of race, gender, and age effects in epidemiological studies...
  20. pmc Patterns of bone sarcomas as a second malignancy in relation to radiotherapy in adulthood and histologic type
    Lindsey C Wu
    Radiation Epidemiology Branch, National Cancer Institute, NIH, HHMI, 6120 Executive Blvd, Rockville, MD 20852, USA
    Cancer Epidemiol Biomarkers Prev 21:1993-9. 2012
    ..It remains uncertain whether radiation is related to other histologic types of bone sarcomas such as chondrosarcomas that are more common in adulthood...
  21. pmc Risk of non-Hodgkin lymphoma after radiotherapy for solid cancers
    Clara J Kim
    Radiation Epidemiology Branch, National Cancer Institute, Bethesda, MD, USA
    Leuk Lymphoma 54:1691-7. 2013
    ..017). There was no clear NHL risk pattern by NHL subtype or age. Our study provides limited evidence that radiotherapy for solid malignancy is associated with increased risk of subsequent NHL. ..
  22. ncbi request reprint Merkel cell carcinoma and multiple primary cancers
    Regan A Howard
    Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, MD 20892 7238, USA
    Cancer Epidemiol Biomarkers Prev 15:1545-9. 2006
    ..Heightened awareness of the associations of lymphohematopoietic malignancies with MCC may facilitate early clinical recognition...
  23. ncbi request reprint The risk of developing second cancers among survivors of childhood soft tissue sarcoma
    Randi J Cohen
    Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Cancer 103:2391-6. 2005
    ..However, the risk for specific cancer sites and variations in risk by treatment and STS histology remain unclear...
  24. pmc Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms: insight into Muir-Torre syndrome
    Graca M Dores
    Medical Service, Department of Veterans Affairs Medical Center, Oklahoma City, OK 73104, USA
    Cancer 113:3372-81. 2008
    ..To the authors' knowledge, only limited information exists regarding incidence patterns of sebaceous carcinoma (SC), and no prior study has quantified risks of associated cancers...
  25. pmc Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004
    Graca M Dores
    Department of Veterans Affairs Medical Center, Medical Service, Oklahoma City, OK 73104, USA
    Br J Haematol 144:86-94. 2009
    ..Five-year relative survival for P-bone, P-extramedullary, and MM varied significantly by age (<60/60+ years), supporting age-related differences in disease burden at presentation, disease biology, and/or treatment approaches...
  26. doi request reprint Prediction of the location and size of the stomach using patient characteristics for retrospective radiation dose estimation following radiotherapy
    Stephanie Lamart
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Phys Med Biol 58:8739-53. 2013
    ..Those dose calculations demonstrated good agreement between predicted and actual stomachs compared with doses derived from a reference model of the body that might be used in the absence of individual CT scan data...
  27. ncbi request reprint New malignancies following childhood cancer in the United States, 1973-2002
    Peter D Inskip
    Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, MD, USA
    Int J Cancer 121:2233-40. 2007
    ....
  28. ncbi request reprint Risk of subsequent cancer following breast cancer in men
    Anssi Auvinen
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892 7362, USA
    J Natl Cancer Inst 94:1330-2. 2002
    ..We conclude that men diagnosed with breast cancer are at high risk of contralateral breast cancer...
  29. ncbi request reprint Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA
    J Natl Cancer Inst 94:182-92. 2002
    ..We quantified the risk of treatment-associated lung cancer, taking into account tobacco use...
  30. ncbi request reprint Prostate radiotherapy is associated with second cancers in many organs, not just the colorectum
    David J Brenner
    Gastroenterology 129:773-4; author reply 774-5. 2005
  31. doi request reprint Assessment of delayed reporting of mycosis fungoides and Sezary syndrome in the United States
    Graca M Dores
    Arch Dermatol 144:413-4. 2008